HESKA CORP - 42805E306
Sector:
Healthcare
· Industry:
In Vitro & In Vivo Diagnostic Substances
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q1 2023
· Q4 2022
Value (USD)
Total reported value ($000)
$629M
QoQ value delta ($000)
+$231.2M
(+58.12%)
Implied price effect (QoQ)
+57.01%
Shares
Total shares
6,443,465
QoQ shares delta
+45,177
(+0.71%)
Total shares held by funds (by quarter)
Top holders (Q1 2023)
Top 25 only
Full list
Early Q2 2023 data: only 2 institutional holders reported so far. More will appear as funds file with the SEC.